Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-29T00:50:14.850Z Has data issue: false hasContentIssue false
  • English
  • Français

Germ and Hematology: Underlying Disease Influences Diversity of Germ Spectra and Antibiotic Therapy

Published online by Cambridge University Press:  10 May 2016

Enrico Schalk ,
Ina Tammer  and
Florian H. Heidel
Enrico Schalk*
Affiliation:
Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany
Ina Tammer
Affiliation:
Institute of Medical Microbiology, Otto-von-Guericke University Medical Center, Magdeburg, Germany
Florian H. Heidel
Affiliation:
Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany
*
Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Medical Center, Leipziger Strasse 44, D-39120 Magdeburg, Germany ([email protected]).
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 2 , February 2014 , pp. 208 - 210
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

References

1. Bossaer, JB, Hall, PD, Garrett-Mayer, E. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer 2010; 19:231–237.Google Scholar
2. Kanamaru, A, Tatsumi, Y. Microbiological data for patients with febrile neutropenia. Clin Infect Dis 2004;39(suppl 1):S7–S10.Google Scholar
3. Zinner, SH. New pathogens in neutropenic patients with cancer: an update for the new millennium. Int J Antimicrob Agents 2000; 16:97–101.Google Scholar
4. Trecarichi, EM, Tumbarello, M, Spanu, T, et al. Incidence and clinical impact of extended-spectrum-(β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 2009;58:299–307.Google Scholar
5. Schalk, E, Tammer, I, König, W, Fischer, T. Epidemiology and antibiotic resistance of bloodstream isolates in haematological patients, 1992-2009. Onkologie 2010;33(suppl 6):193.Google Scholar
6. Rolston, KV. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia. Clin Infect Dis 2005;40(suppl 4):S246–S252.CrossRefGoogle ScholarPubMed